Metal complexes of saccharin and thiosaccharin as potential anticancer and antimicrobial agents

Ceyda Icsel , Veysel T. Yilmaz , Okan Z. Yesilel , William T.A. Harrison
{"title":"Metal complexes of saccharin and thiosaccharin as potential anticancer and antimicrobial agents","authors":"Ceyda Icsel ,&nbsp;Veysel T. Yilmaz ,&nbsp;Okan Z. Yesilel ,&nbsp;William T.A. Harrison","doi":"10.1016/j.ejmcr.2024.100205","DOIUrl":null,"url":null,"abstract":"<div><p>Based on the chemotherapeutic success of cisplatin, carboplatin and oxaliplatin as anticancer drugs, and silver sulfadiazine (AgSDZ) as an antibacterial drug, exploration of the anticancer and antibacterial potential of new metal complexes has received increasing attention during the last three decades. Saccharin (sacH) is a well-known worldwide artificial sweetener. Its deprotonated form (sac) is a polyfunctional ligand, coordinating to different metals due to the presence of hard and soft donor sites (see comment below). In the last two decades, a large number of mixed-ligand metal complexes containing sac and tsac ligands have been synthesized and in some cases, they have demonstrated better <em>in vitro</em> and <em>in vivo</em> biological activities than approved standard drugs. This review describes the design, anticancer and antimicrobial activity screening of metal complexes of sac and its thio derivative (tsac) as prospective drug candidates. The metal sac complexes herein are categorized according to the ancillary ligands present in the complexes, and their anticancer and antimicrobial activities are discussed in detail. The main molecular targets and cellular pathways involved in the mechanism of action of the metal complexes were also explored. The growing field demonstrates promising <em>in vitro</em> and <em>in vivo</em> results with a significant interest for future research in medicinal inorganic chemistry.</p></div>","PeriodicalId":12015,"journal":{"name":"European Journal of Medicinal Chemistry Reports","volume":"12 ","pages":"Article 100205"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772417424000773/pdfft?md5=49e2a34d02c60c755a37c3ac401e827b&pid=1-s2.0-S2772417424000773-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772417424000773","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Based on the chemotherapeutic success of cisplatin, carboplatin and oxaliplatin as anticancer drugs, and silver sulfadiazine (AgSDZ) as an antibacterial drug, exploration of the anticancer and antibacterial potential of new metal complexes has received increasing attention during the last three decades. Saccharin (sacH) is a well-known worldwide artificial sweetener. Its deprotonated form (sac) is a polyfunctional ligand, coordinating to different metals due to the presence of hard and soft donor sites (see comment below). In the last two decades, a large number of mixed-ligand metal complexes containing sac and tsac ligands have been synthesized and in some cases, they have demonstrated better in vitro and in vivo biological activities than approved standard drugs. This review describes the design, anticancer and antimicrobial activity screening of metal complexes of sac and its thio derivative (tsac) as prospective drug candidates. The metal sac complexes herein are categorized according to the ancillary ligands present in the complexes, and their anticancer and antimicrobial activities are discussed in detail. The main molecular targets and cellular pathways involved in the mechanism of action of the metal complexes were also explored. The growing field demonstrates promising in vitro and in vivo results with a significant interest for future research in medicinal inorganic chemistry.

Abstract Image

糖精和硫代糖精的金属复合物作为潜在的抗癌剂和抗菌剂
在顺铂、卡铂和奥沙利铂作为抗癌药物以及磺胺嘧啶银(AgSDZ)作为抗菌药物取得化疗成功的基础上,对新型金属复合物的抗癌和抗菌潜力的探索在过去三十年中受到越来越多的关注。糖精(saccharin,sacH)是一种世界知名的人工甜味剂。它的去质子化形式(sac)是一种多官能团配体,由于存在软硬供体位点,可与不同的金属配位(见下文注释)。在过去的二十年里,人们合成了大量含有囊配体和沙克配体的混合配体金属复合物,在某些情况下,它们在体外和体内表现出了比已批准的标准药物更好的生物活性。本综述介绍了作为候选药物的囊及其硫代衍生物(tsac)金属配合物的设计、抗癌和抗菌活性筛选。本文根据络合物中存在的辅助配体对金属囊络合物进行了分类,并详细讨论了它们的抗癌和抗菌活性。此外,还探讨了金属复合物作用机制中涉及的主要分子靶点和细胞途径。这一不断发展的领域在体外和体内都取得了可喜的成果,对未来的药用无机化学研究具有重大意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信